FLAM regimen

chemotherapy protocol consisting of the vidarabine derivative fludarabine plus the other compounds above; used for treatment of acute leukemia and the blastic phase of chronic myelogenous leukemia

Also Known As:

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Therapy Context: Research Results

Experts

1.	Doyle, L Austin: 1 article (07/2017)
2.	Gobburu, Joga: 1 article (07/2017)
3.	Greer, Jacqueline M: 1 article (07/2017)
4.	Ivaturi, Vijay: 1 article (07/2017)
5.	Karp, Judith E: 1 article (07/2017)
6.	LaCerte, Carl: 1 article (07/2017)
7.	Rudek, Michelle A: 1 article (07/2017)
8.	Wright, John J: 1 article (07/2017)
9.	Knapper, Steven: 1 article (09/2015)

Related Diseases

1.	Leukemia 07/15/2017 - "Further trials in newly diagnosed patients with acute leukemia should utilize the bolus FLAM regimen at the MTD of 50 mg/m2/day. " 12/01/1999 - "Fifty-five adults with relapsed or refractory acute leukemia or the blastic phase of chronic myelogenous leukemia (CML) received salvage therapy with the FLAM regimen, which consisted of fludarabine, cytarabine, and increasing doses of mitoxantrone. "
2.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/01/2015 - "The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia."
3.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/01/1999 - "Fifty-five adults with relapsed or refractory acute leukemia or the blastic phase of chronic myelogenous leukemia (CML) received salvage therapy with the FLAM regimen, which consisted of fludarabine, cytarabine, and increasing doses of mitoxantrone. "

Related Drugs and Biologics

1.	Mitoxantrone (Novantrone)
2.	Cytarabine (Cytosar-U)
3.	fludarabine

Related Therapies and Procedures

1.	Salvage Therapy
2.	Therapeutics